 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | GFS101A / GenFleet Therap, Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors (clinicaltrials.gov) - May 20, 2022
P1/2, N=0, Withdrawn, Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd.
N=96 --> 0 | Trial completion date: Apr 2025 --> May 2022 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2024 --> May 2022
- |||| GFS101A / GenFleet Therap, Loqtorzi (toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
New P1/2 trial: A Study of GFS101A in Combination With Toripalimab in Patients With Advanced Solid Tumors (clinicaltrials.gov) - Dec 21, 2021
P1/2, N=96, Not yet recruiting, Sponsor: Zhejiang Genfleet Therapeutics Co., Ltd.